to pay any more than what . . . class members are entitled to under the theories of liability that existed at the time the settlement was reached." Warfarin Sodium, 391 F.3d. at 538. Here, as Plaintiffs state, "Defendants operate a successful, well-known, multi-national automobile business." ECF No. 28. Even i

to trial. A district court retains the authority to decertify or modify a class at any time during the litigation if it proves to be unmanageable." Warfarin Sodium, 391 F.3d at 537 (citing Prudential, 148 F.3d at 321). Because of this, the "specter of decertification makes settlement an appealing alternative."

to pay any more than what . . . class members are entitled to under the theories of liability that existed at the time the settlement was reached." Warfarin Sodium, 391 F.3d. at 538. Here, as Plaintiffs state, "Defendants operate a successful, well-known, multi-national automobile business." ECF No. 28. Even i

to pay any more than what . . . class members are entitled to under the theories of liability that existed at the time the settlement was reached." Warfarin Sodium, 391 F.3d. at 538. Here, as Plaintiffs state, "Defendants operate a successful, well-known, multi-national automobile business." ECF No. 28. Even i

to trial. A district court retains the authority to decertify or modify a class at any time during the litigation if it proves to be unmanageable." Warfarin Sodium, 391 F.3d at 537 (citing Prudential, 148 F.3d at 321). Because of this, the "specter of decertification makes settlement an appealing alternative."

ire "additional discovery, extensive pretrial motions addressing complex factual and legal questions, and ultimately a complicated, lengthy trial." Warfarin Sodium, 391 F.3d at 536. The action here, which has been pending for over three years, would require the analysis of records from "hundreds of consumers,"